BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

Search

EssilorLuxottica SA

Avatud

SektorTervishoid

252.2 0.44

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

250.1

Max

255.1

Põhinäitajad

By Trading Economics

Sissetulek

-371M

994M

Müük

-72M

13B

P/E

Sektori keskmine

48.301

57.333

Aktsiakasum

2.976

Dividenditootlus

1.6

Kasumimarginaal

7.52

Töötajad

153,498

EBITDA

635M

3.6B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+12.78% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.60%

2.63%

Järgmine tulemuste avaldamine

24. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-8.6B

113B

Eelmine avamishind

251.76

Eelmine sulgemishind

252.2

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

EssilorLuxottica SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. apr 2025, 18:17 UTC

Tulu

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

23. apr 2025, 16:36 UTC

Tulu

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

12. veebr 2025, 18:35 UTC

Tulu

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

12. veebr 2025, 17:32 UTC

Tulu

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2. jaan 2025, 17:29 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Buys AI Startup in Hearing Market Push

24. apr 2025, 09:58 UTC

Market Talk
Tulu

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

24. apr 2025, 09:35 UTC

Market Talk
Tulu

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

24. apr 2025, 08:11 UTC

Market Talk
Tulu

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

3. apr 2025, 08:00 UTC

Market Talk

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

28. märts 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13. veebr 2025, 11:05 UTC

Market Talk
Tulu

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13. veebr 2025, 10:54 UTC

Market Talk
Tulu

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

13. veebr 2025, 08:41 UTC

Market Talk
Tulu

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

12. veebr 2025, 17:05 UTC

Tulu

EssilorLuxottica Backs Mid-Term Targets

12. veebr 2025, 17:05 UTC

Tulu

EssilorLuxottica 2024 Oper Pft EUR3.45B

12. veebr 2025, 17:04 UTC

Tulu

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

12. veebr 2025, 17:04 UTC

Tulu

EssilorLuxottica 2024 Net Pft EUR2.36B

12. veebr 2025, 17:03 UTC

Tulu

EssilorLuxottica 2024 Rev EUR26.51B

12. veebr 2025, 17:03 UTC

Tulu

EssilorLuxottica 4Q Rev EUR6.78B

12. veebr 2025, 17:01 UTC

Tulu

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

12. veebr 2025, 17:00 UTC

Tulu

EssilorLuxottica Declares Dividend of EUR3.95 a share

11. veebr 2025, 16:30 UTC

Market Talk

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

11. veebr 2025, 10:58 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

11. veebr 2025, 07:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Doesn't Disclose Financial Details

11. veebr 2025, 07:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

11. veebr 2025, 07:02 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

11. veebr 2025, 07:01 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

11. veebr 2025, 07:00 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica to Buy Cellview

2. jaan 2025, 17:04 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Didn't Disclose Financial Details

2. jaan 2025, 17:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

Võrdlus sarnastega

Hinnamuutus

EssilorLuxottica SA Prognoos

Hinnasiht

By TipRanks

12.78% tõus

12 kuu keskmine prognoos

Keskmine 284.2 EUR  12.78%

Kõrge 335 EUR

Madal 245 EUR

Põhineb 11 Wall Streeti analüütiku instrumendi EssilorLuxottica SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

7

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

246.5 / 253.2Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

No Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.